You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Messenger RNA

Showing 1 - 25 of 1,867
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Identify microRNAs in Cachexia in Pancreatic Carcinoma

Recruiting
  • Resectable Pancreatic Adenocarcinoma
  • Pancreatic cancer microRNA and messenger RNA expression.
  • Oklahoma City, Oklahoma
    Stephenson Cancer Center
Jan 9, 2023

Healthy Adult Volunteers Trial in Taipei City (ChAdOx1-nCov-19 (Astra-Zeneca), SARS-CoV-2 messenger RNA-1273 (Moderna) vaccine)

Completed
  • Healthy Adult Volunteers
  • ChAdOx1-nCov-19 (Astra-Zeneca)
  • SARS-CoV-2 messenger RNA-1273 (Moderna) vaccine
  • Taipei City, X, Taiwan
    National Taiwan University Hospital
Oct 16, 2022

Corona Virus Disease 2019(COVID-19) Trial in Chengdu (0.3ml of mRNA vaccine)

Enrolling by invitation
  • Corona Virus Disease 2019(COVID-19)
  • 0.3ml of mRNA vaccine
  • Chengdu, China
    West China Second University Hospital
Oct 3, 2022

COVID-19, Corona Virus Infection Trial in Ann Arbor (Pfizer-BioNTech mRNA COVID-19 vaccine, Moderna mRNA COVID-19 vaccine)

Recruiting
  • COVID-19
  • Corona Virus Infection
  • Pfizer-BioNTech mRNA COVID-19 vaccine
  • Moderna mRNA COVID-19 vaccine
  • Ann Arbor, Michigan
    University of Michigan
Apr 23, 2022

Breast Cancer Female, Early-stage Breast Cancer Trial in Jette (Trimix, Placebo)

Recruiting
  • Breast Cancer Female
  • Early-stage Breast Cancer
  • Jette, Brussel, Belgium
    UZ Brussel
May 18, 2022

mRNA and miRNA Airway Inflammatory Markers

Completed
  • COPD
  • COPD Exacerbation
    • Groningen, Netherlands
      University Medical Center; Department of Pulmonary Diseases
    Jul 8, 2021

    Melanoma, Colon Cancer, Gastrointestinal Cancer Trial run by the NCI (National Cancer Institute (NCI)-4650, a messenger

    Terminated
    Has Results
    • Melanoma
    • +4 more
    • National Cancer Institute (NCI)-4650, a messenger ribonucleic acid (mRNA)-based, Personalized Cancer Vaccine
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    May 22, 2020

    Triple Negative Breast Cancer, Breast Cancer Trial in Shanghai (docetaxel, doxorubicin or epirubicin, cyclophosphamide)

    Unknown status
    • Triple Negative Breast Cancer
    • Breast Cancer
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Apr 22, 2020

    Barrett's Esophagus and Esophageal Adenocarcinoma, Searching for

    Recruiting
    • Esophageal Neoplasms
      • Ghent, Oost-Vlaanderen, Belgium
        University hospital Ghent
      Jan 13, 2023

      Sepsis, Emergent Infections, Treatment Trial (Droplet digital PCR)

      Not yet recruiting
      • Sepsis
      • Emergent Infections, Treatment
      • Droplet digital PCR
      • (no location specified)
      Sep 5, 2023

      Male Infertility Trial in Hamilton (Active multi-ingredient supplement (Fertility Enhancer, FE), Inactive (Placebo; PLA))

      Not yet recruiting
      • Male Infertility
      • Active multi-ingredient supplement (Fertility Enhancer, FE)
      • Inactive placebo (Placebo; PLA)
      • Hamilton, Ontario, Canada
        Mark Tarnopololsky
      Oct 23, 2023

      Healthy Trial in Ann Arbor (High-sodium diet 300 mmol sodium/day, Low-sodium diet 10 mmol sodium/day)

      Completed
      • Healthy
      • High-sodium diet 300 mmol sodium/day
      • Low-sodium diet 10 mmol sodium/day
      • Ann Arbor, Michigan
        University of Michigan
      Feb 4, 2022

      Thyroid Nodule (Diagnosis), Thyroid Cancer Trial in Aarhus N (Molecular analyses)

      Enrolling by invitation
      • Thyroid Nodule (Diagnosis)
      • Thyroid Cancer
      • Molecular analyses
      • Aarhus N, Denmark
        Aarhus Universityhospital
      May 16, 2022

      Vaccine-generated Immunity in Ocrelizumab-treated Patients:

      Active, not recruiting
      • Multiple Sclerosis
      • SARS-COV-2 mRNA Vaccine
      • Denver, Colorado
      • +1 more
      Apr 4, 2022

      Covid19 Trial in Cairo (Astrazeneca/Oxford Vaccine, Sinopharm vaccine)

      Recruiting
      • Covid19
      • Astrazeneca/Oxford Vaccine
      • Sinopharm vaccine
      • Cairo, Non-US, Egypt
        Faculty of Medicine Ain Shams University Research Institute- Cli
      May 8, 2021

      Severe Exacerbation of Severe Acute Respiratory Syndrome

      Active, not recruiting
      • SARS-CoV-2
        • Tokyo, Japan
          CMIC Co. Ltd.,
        Jun 5, 2023

        Japan After Severe Acute Respiratory Syndrome Coronavirus 2

        Not yet recruiting
        • SARS-CoV-2
          • Tokyo, Japan
            CMIC Co., Ltd
          Jun 6, 2023

          Post-marketing Safety of Elasomeran/Davesomeran and Andusomeran

          Recruiting
          • SARS-CoV-2
          • SPIKEVAX
          • New York, New York
            Aetion, Inc
          Nov 8, 2023

          Japan of Shock and Anaphylaxis After Severe Acute Respiratory

          Active, not recruiting
          • SARS-CoV-2
            • Tokyo, Japan
              CMIC Co., Ltd.
            Jun 5, 2023

            Platelet Aggregation Inhibitors, Aspirin, Ticagrelor Trial in Durham (Aspirin, Ticagrelor)

            Completed
            • Platelet Aggregation Inhibitors
            • +3 more
            • Durham, North Carolina
              Duke University
            Mar 4, 2022

            Electromagnetic Radiation (5GFR2) Trial (5GFR2 non ionizing EMW exposure)

            Not yet recruiting
            • Electromagnetic Radiation (5GFR2)
            • 5GFR2 non ionizing EMW exposure
            • (no location specified)
            Jun 28, 2023

            Familial Chylomicronemia Syndrome Trial (VSA001 injection, Placebo)

            Not yet recruiting
            • Familial Chylomicronemia Syndrome
            • VSA001 injection
            • Placebo
            • (no location specified)
            Jun 9, 2023

            Postural Tachycardia Syndrome Trial in Nashville (NET mRNA level, Plasma catechols, Urine Catechols)

            Enrolling by invitation
            • Postural Tachycardia Syndrome
            • NET mRNA level
            • +2 more
            • Nashville, Tennessee
              Vanderbilt University Medical Center
            Sep 4, 2021

            Post Authorization Safety Study Moderna COVID-19 Primary Vaccine

            Completed
            • COVID-19
            • Moderna COVID-19 Vaccine
            • Jakarta Pusat, Jakarta, Indonesia
            • +17 more
            Aug 22, 2023

            COVID-19 Trial in Melbourne (Tozinameran - Standard dose, Tozinameran - fractional dose, Elasomeran - standard dose)

            Active, not recruiting
            • COVID-19
            • Tozinameran - Standard dose
            • +3 more
            • Melbourne, Victoria, Australia
              Royal Children's Hospital
            Aug 24, 2022